Press Releases Surmodics, Inc.

Equities

SRDX

US8688731004

Real-time Estimate Cboe BZX Other stock markets 03:01:26 2024-06-06 pm EDT			5-day change	1st Jan Change
41.96 ^USD	-0.07%		-0.36%	+15.41%

May. 30	Barrington Research Downgrades SurModics to Market Perform From Outperform	MT
May. 29	Needham Downgrades SurModics to Hold From Buy	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc.	May. 29	PR
Shareholder Alert: Ademi LLP investigates whether Surmodics, Inc. has obtained a Fair Price for its Public Shareholders	May. 29	PR
SRDX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Surmodics to GTCR	May. 29	AQ
SRDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surmodics, Inc. Is Fair to Shareholders	May. 29	BU
Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million	May. 29	BU
SurModics: Fiscal Q2 Earnings Snapshot	May. 01	AQ
Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance	May. 01	BU
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1	Apr. 22	AQ
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1	Apr. 19	BU
Surmodics to Participate in Upcoming Investor Conferences in March and April	Feb. 27	BU
Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results, Updates Fiscal Year 2024 Financial Guidance	Feb. 02	AQ
SurModics: Fiscal Q1 Earnings Snapshot	Feb. 01	AQ
Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance	Feb. 01	BU
Surmodics Announces Successful Early Clinical Use of Pounce LP Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli below the Knee	Jan. 23	AQ
Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee	Jan. 22	BU
Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1	Jan. 16	BU
Surmodics to Host Virtual Annual Meeting of Shareholders	Jan. 16	BU
Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium	Nov. 16	BU
Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium	Nov. 16	BU
Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28	Nov. 14	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Surmodics, Inc.

Equities

SRDX

US8688731004

Press Releases

Filters